Home
Scholarly Works
Fluvoxamine for the treatment of COVID-19 –...
Journal article
Fluvoxamine for the treatment of COVID-19 – Author's reply
Authors
Reis G; Mills E
Journal
The Lancet Global Health, Vol. 10, No. 3,
Publisher
Elsevier
Publication Date
March 1, 2022
DOI
10.1016/s2214-109x(21)00588-x
ISSN
2572-116X
Associated Experts
Edward Joseph Mills
Professor (Part-Time), Faculty of Health Sciences
Visit profile
Gilmar Reis
Associate Professor (Part-Time), Faculty of Health Sciences
Visit profile
Labels
Fields of Research (FoR)
4202 Epidemiology
4203 Health services and systems
4206 Public health
42 Health Sciences
Medical Subject Headings (MeSH)
Fluvoxamine
Humans
SARS-CoV-2
COVID-19 Drug Treatment
View published work (Non-McMaster Users)
View published work (McMaster Users)
Scholarly citations from Dimensions
Contact the Experts team
Get technical help
or
Provide website feedback